Biogen Idec MA Inc.

GPTKB entity

Statements (59)
Predicate Object
gptkbp:instance_of gptkb:biotechnology
gptkbp:acquisition gptkb:Gene_Therapies,_Inc.
gptkb:Zymeworks
gptkb:Acorda_Therapeutics
gptkb:Idec_Pharmaceuticals
gptkb:Onco_Immune
Nightstar Therapeutics
gptkbp:ceo gptkb:Michel_Vounatsos
gptkbp:employees 7,000+
gptkbp:focus neurological diseases
gptkbp:founded gptkb:1978
gptkbp:founder M. A. (M. A.)
gptkbp:headquarters gptkb:Cambridge,_MA
gptkb:Cambridge,_Massachusetts
https://www.w3.org/2000/01/rdf-schema#label Biogen Idec MA Inc.
gptkbp:industry gptkb:biotechnology
gptkbp:partnership gptkb:UCB_S._A.
gptkb:GSK
gptkb:Johnson_&_Johnson
gptkb:Samsung_Bioepis
gptkb:Takeda_Pharmaceutical_Company
gptkb:Alnylam_Pharmaceuticals
gptkb:Sobi_AB
gptkb:Astra_Zeneca
gptkb:Sanofi
gptkb:Bayer_AG
gptkb:Boehringer_Ingelheim
gptkb:Bristol-Myers_Squibb
gptkb:Eisai_Co.,_Ltd.
gptkb:Pfizer
gptkb:Regeneron_Pharmaceuticals
gptkb:Horizon_Therapeutics
gptkb:Merck_&_Co.
gptkb:Roche
gptkb:Amgen
gptkb:Astellas_Pharma
gptkb:Eli_Lilly_and_Company
gptkb:Vertex_Pharmaceuticals
gptkb:Ionis_Pharmaceuticals
gptkb:Abb_Vie
gptkb:Sarepta_Therapeutics
gptkb:Cure_Vac
gptkb:Novartis
gptkbp:products gptkb:Tecfidera
gptkb:Avonex
gptkb:Tysabri
gptkbp:related_products gptkb:Spinraza
gptkb:Aducanumab
gptkbp:research_focus gptkb:amyotrophic_lateral_sclerosis
gptkb:muscular_dystrophy
gptkb:multiple_sclerosis
gptkbp:revenue $13.45 billion (2020)
gptkbp:stock_symbol gptkb:BIIB
gptkbp:subsidiary gptkb:Biogen_International_Gmb_H
gptkbp:traded_on gptkb:NASDAQ
gptkbp:type gptkb:public_company
gptkbp:website www.biogen.com
gptkbp:bfsParent gptkb:Biogen_Idec
gptkbp:bfsLayer 5